Log in
Enquire now
‌

US Patent 9352051 Kits containing DLL3 antibody drug conjugates

Patent 9352051 was granted and assigned to Stemcentrx, Inc. on May, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Stemcentrx, Inc.
Current Assignee
‌
Stemcentrx, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9352051
Date of Patent
May 31, 2016
Patent Application Number
15005962
Date Filed
January 25, 2016
Patent Citations Received
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
‌
US Patent 11976125 B cell maturation antigen binding proteins
0
Patent Primary Examiner
‌
Christine J. Saoud
Patent abstract

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9352051 Kits containing DLL3 antibody drug conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.